A Pilot Study Comparing LY3410738 Capsule and Tablet Formulations and Effect of a Low-fat Meal and a Proton Pump Inhibitor on the Single-dose Pharmacokinetics of LY3410738 Tablets in Healthy Adult Subjects
Latest Information Update: 29 Dec 2023
At a glance
- Drugs LY 3410738 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
Most Recent Events
- 29 Dec 2023 New trial record